Introduction: The optimal hemoglobin A1c (glycated hemoglobin; HbA1c) target in diabetic
patients on haemodialysis is not established. Most guidelines suggest a HbA1c target of 7%-
Objectives: There is paucity of Indian data on the optimal HbA1c values to be targeted in
dialysis patients, and hence this prospective study was undertaken to address this gap.
Patients and Methods: This prospective study was conducted in 61 prevalent maintenance
haemodialysis patients with type 2 diabetes mellitus. We looked at the association of HbA1c
with 1-year survival and hemoglobin values.
Results: At the end of one year, 38 patients had survived, 10 patients died, 3 patients were
transferred to continuous ambulatory peritoneal dialysis, and 10 patients were transferred to
other centres. There was a significant relationship between HbA1c levels and blood hemoglobin
values (r=0.245, P=0.05). The HbA1c values of non-survived patients (7.350 ± 1.834) were
higher than those survived (6.768 ± 1.602), though not statistically significant (P=0.326).
Conclusion: This study shows that in diabetic nephropathy patients, poor glycemic control
could be a factor for decreased survival rates on haemodialysis. However, larger prospective
studies are required to establish the relationship.